| Walgreen Won't Sell Genetic Test Until Maker Works Out Issues With FDA Walgreen said it won't sell an over-the-counter genetic test until the company that makes the test works out any regulatory issues with the FDA. online.wsj.com |
Medicaid Stalemate Tests States A number of states are preparing to make deep cuts to Medicaid as a federal stalemate over funding for the poor drags on—even as they face mandates to expand the program under the new health-care law. online.wsj.com |
IPO Market Sizzles - In China The Burrill Report submits: Wondering if the IPO window is open? Well there’s no doubt about it if you are talking about the IPO market in China. The life sciences sector has raised $6.1 billion through initial public offerings in the past 12 months, far outpacing the activity in the United States. And, despite the collapse of Charles River's (CRL) $1.6 billion acquisition of Wuxi (WX), M&A activity is growing.We spoke to Greg Scott, president and founder of the consulting firm ChinaBio and publisher of ChinaBio Today, about the thriving IPO market for life sciences companies there, how that’s evolved over the past year and what the outlook is moving forward.Complete Story » seekingalpha.com |
Diabetes Drug Hits Hurdle Germany's Merck suffered a major blow when an advisory panel of the European Medicines Agency issued a negative opinion on multiple-sclerosis treatment Cladribine. online.wsj.com |
American Medical Association To Offer Quest Diagnostics Care360 EHR On Its New Online Physician Platform [PR Newswire] - Quest Diagnostics' healthcare information technology subsidiary MedPlus and the American Medical Association , the nation's largest physician organization, today announced they are partnering to expand the adoption of health information technology by offering Care360â„¢ EHR, a web-based electronic health record, on the AMA's new online platform for physicians. us.rd.yahoo.com |